Factor Xa Inhibitor Related ICH & PCCs
Background: Factor Xa inhibitors have gained more use over the past several years due to the ease of administration and easier monitoring. However, bleeding, namely intracranial hemorrhage (ICH) is still a risk and the lack of a proven antidote is a cause for concern. Guidelines for the treatment of ICH published in 2016 recommended the … Continue reading Factor Xa Inhibitor Related ICH & PCCs
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed